International Journal of Clinical Research

Objective To analyze the therapeutic effect of using oseltamivir phosphate combined with prednisolone anti-inflammatory oral solution on children with influenza virus infection. Methods 68 pediatric patients with influenza virus infection who visited our hospital from March 2021 to 2023 were randomly divided into a control group of 34 cases receiving treatment with oseltamivir phosphate, and an observation group of 35 cases receiving treatment with Pudillan anti-inflammatory oral solution. The clinical symptom improvement time and adverse reactions of the two groups were compared; Results After treatment, the improvement time of clinical symptoms in the observation group was significantly better than that in the control group, with a difference of P<0.05. At the same time, the difference in adverse reactions between the two groups was small and not significant, with P>0.05. Conclusion The combination of oseltamivir phosphate and prednisolone anti-inflammatory oral solution has a good therapeutic effect on children with influenza virus infection, accelerates the improvement of symptoms in children, benefits physical comfort, and is relatively safe to treat, with no obvious adverse reactions.

Oseltamivir phosphate; Pudi Lan Anti Inflammatory Oral Liquid; Pediatric influenza virus infection